Stoneridge Investment Partners Has Upped Its Mylan (MYL) Holding; Acadia Healthcare (ACHC) Stock Price Declined While Courage Capital Management Has Upped Stake by $2.98 Million

Mylan N.V. (NASDAQ:MYL) Logo

Courage Capital Management Llc increased its stake in Acadia Healthcare (ACHC) by 21.25% based on its latest 2018Q3 regulatory filing with the SEC. Courage Capital Management Llc bought 85,000 shares as the company’s stock declined 17.81% with the market. The hedge fund held 485,000 shares of the health care company at the end of 2018Q3, valued at $17.07M, up from 400,000 at the end of the previous reported quarter. Courage Capital Management Llc who had been investing in Acadia Healthcare for a number of months, seems to be bullish on the $2.39B market cap company. The stock decreased 0.44% or $0.12 during the last trading session, reaching $27.04. About 735,583 shares traded. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 1.83% since February 13, 2018 and is downtrending. It has underperformed by 1.83% the S&P500. Some Historical ACHC News: 15/03/2018 – Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of a Securities Class Action Against Acadia Healthcare Company, Inc. (ACHC); 02/04/2018 – Fidelity Health Care Services Adds Acadia Health; 01/05/2018 – Acadia Healthcare 1Q EPS 58c; 11/05/2018 – Saint Thomas Health and Acadia Healthcare Announce Plans to Develop a Psychiatric Inpatient Hospital in Nashville, Tennessee; 11/05/2018 – Saint Thomas Health and Acadia Healthcare Announce Plans to Develop a Psychiatric lnpatient Hospital in Nashville, Tennessee; 12/03/2018 – Moody’s assigns B3 CFR to Elysium, stable outlook; 11/05/2018 – ACADIA HEALTHCARE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc; 15/05/2018 – Pennant Capital Management LLC Exits Position in Acadia Health; 13/03/2018 – Rep. Bruce Poliq: Acadia Harvesting and Boundary Disputes Bill Passes House, Led by Poliquin and Cosponsored by Pingree; 07/05/2018 – Acadia Health Forms Golden Cross: Technicals

Stoneridge Investment Partners Llc increased its stake in Mylan Inc (MYL) by 19.95% based on its latest 2018Q3 regulatory filing with the SEC. Stoneridge Investment Partners Llc bought 14,263 shares as the company’s stock declined 20.24% with the market. The institutional investor held 85,740 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $3.14 million, up from 71,477 at the end of the previous reported quarter. Stoneridge Investment Partners Llc who had been investing in Mylan Inc for a number of months, seems to be bullish on the $16.15B market cap company. The stock decreased 1.31% or $0.42 during the last trading session, reaching $31.32. About 3.52M shares traded. Mylan N.V. (NASDAQ:MYL) has declined 18.92% since February 13, 2018 and is downtrending. It has underperformed by 18.92% the S&P500. Some Historical MYL News: 28/03/2018 – MYLAN INVESTORS CAN PROCEED WITH SUIT OVER EPIPEN PRICING; 14/05/2018 – U.S. Food and Drug Administration Accepts and Acknowledges Coherus BioSciences Biologics License Application of CHS-1701 (Pegfilgrastim Biosimilar Candidate) for Review; 28/03/2018 – Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S; 21/03/2018 – Mylan to Host Investor Day on April 11, 2018, in New York City; 21/04/2018 – Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone® at American Academy of Neurology 70th Annual Meeting; 11/04/2018 – MYLAN – ACQUIRED GLOBAL DEVELOPMENT & MARKETING RIGHTS FROM PRAYOG LABS TO BRING TO MARKET FAST-ACTING MELOXICAM AS PROPOSED NON-NARCOTIC ANALGESIC; 14/05/2018 – NICE RECOMMENDS EXTAVIA, COPAXONE, AVONEX, REBIF FOR MS; 10/05/2018 – MYLAN GETS INVESTIGATIVE DEMAND FROM DOJ OVER TAA COMPLIANCE; 23/04/2018 – Mylan Presenting at Conference Apr 27; 13/04/2018 – MYLAN IS SAID IN TALKS TO ACQUIRE MERCK KGAA’S UNIT: RTRS

More notable recent Acadia Healthcare Company, Inc. (NASDAQ:ACHC) news were published by: Seekingalpha.com which released: “Video Breakdown Gives Skewed Viewpoint For Future Of Acadia Healthcare – Seeking Alpha” on January 04, 2019, also Nasdaq.com with their article: “December 2019 Options Now Available For Acadia Healthcare Company (ACHC) – Nasdaq” published on October 15, 2018, Seekingalpha.com published: “Acadia Healthcare: Former Patients, Staff, And U.K. Media Outlet Corroborate Findings While Opioid Crisis Persists – Seeking Alpha” on December 03, 2018. More interesting news about Acadia Healthcare Company, Inc. (NASDAQ:ACHC) were released by: Digitaljournal.com and their article: “NASDAQ: ACHC Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Acadia Healthcare Company Inc – Press Release – Digital Journal” published on October 15, 2018 as well as Nasdaq.com‘s news article titled: “Is Acadia Healthcare (ACHC) a Great Stock for Value Investors Right Now? – Nasdaq” with publication date: March 19, 2018.

Since November 1, 2018, it had 0 insider purchases, and 1 insider sale for $1.88 million activity.

Investors sentiment increased to 1.63 in 2018 Q3. Its up 0.16, from 1.47 in 2018Q2. It is positive, as 22 investors sold ACHC shares while 56 reduced holdings. 37 funds opened positions while 90 raised stakes. 102.30 million shares or 6.45% less from 109.35 million shares in 2018Q2 were reported. Oak Ridge Investments Limited Liability, Illinois-based fund reported 473,183 shares. Aristotle Boston Ltd stated it has 416,328 shares or 1.08% of all its holdings. 10,391 are owned by Teacher Retirement Of Texas. Retirement Of Alabama holds 114,024 shares or 0.02% of its portfolio. 8,751 are held by Strs Ohio. Levin Cap Strategies LP owns 15,960 shares. State Of Alaska Department Of Revenue has 0.01% invested in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Enterprise Financial Svcs Corporation has invested 0% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Qs Limited Liability Company stated it has 0% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Tower Research Limited Liability Company (Trc) holds 8,786 shares or 0.02% of its portfolio. Leuthold Gp Limited Liability Com holds 0.72% or 186,986 shares. Tcw reported 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Bb&T Corp holds 53,180 shares or 0.03% of its portfolio. Retail Bank Of Mellon holds 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 1.03M shares. Vanguard Gru Inc reported 7.40 million shares.

Among 17 analysts covering Acadia Healthcare (NASDAQ:ACHC), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. Acadia Healthcare had 58 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 19 by RBC Capital Markets. Credit Suisse initiated Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Friday, November 3 with “Hold” rating. The firm earned “Strong Buy” rating on Thursday, November 3 by Raymond James. The rating was maintained by BMO Capital Markets on Thursday, October 26 with “Outperform”. Cantor Fitzgerald maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Wednesday, October 25 with “Neutral” rating. As per Thursday, August 6, the company rating was maintained by Cantor Fitzgerald. Robert W. Baird maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Wednesday, December 13 with “Hold” rating. Jefferies maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Tuesday, July 31. Jefferies has “Buy” rating and $47 target. KeyBanc Capital Markets maintained the shares of ACHC in report on Wednesday, January 11 with “Overweight” rating. UBS maintained the stock with “Buy” rating in Monday, July 31 report.

Stoneridge Investment Partners Llc, which manages about $1.01 billion and $470.15 million US Long portfolio, decreased its stake in Coty Inc (NYSE:COTY) by 32,673 shares to 133,816 shares, valued at $1.68 million in 2018Q3, according to the filing. It also reduced its holding in Avery Dennison Corp Com (NYSE:AVY) by 5,484 shares in the quarter, leaving it with 19,195 shares, and cut its stake in Carnival Corp (NYSE:CCL).

Among 23 analysts covering Mylan Inc. (NASDAQ:MYL), 16 have Buy rating, 0 Sell and 7 Hold. Therefore 70% are positive. Mylan Inc. had 88 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Mylan N.V. (NASDAQ:MYL) earned “Hold” rating by RBC Capital Markets on Friday, October 20. The rating was downgraded by Mizuho to “Neutral” on Friday, October 5. Mizuho maintained it with “Buy” rating and $47 target in Friday, November 18 report. The firm earned “Overweight” rating on Wednesday, November 18 by JP Morgan. The stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given on Friday, August 4 by RBC Capital Markets. The stock of Mylan N.V. (NASDAQ:MYL) earned “Equal-Weight” rating by Morgan Stanley on Tuesday, November 6. The stock of Mylan N.V. (NASDAQ:MYL) has “Buy” rating given on Thursday, January 4 by Citigroup. UBS downgraded Mylan N.V. (NASDAQ:MYL) rating on Wednesday, January 23. UBS has “Neutral” rating and $32 target. The stock of Mylan N.V. (NASDAQ:MYL) earned “Outperform” rating by Raymond James on Thursday, August 9. The firm earned “Buy” rating on Tuesday, June 5 by Guggenheim.

More notable recent Mylan N.V. (NASDAQ:MYL) news were published by: Seekingalpha.com which released: “FDA OKs Mylan’s Advair generic; shares up 7% – Seeking Alpha” on January 30, 2019, also Nasdaq.com with their article: “February 2019 Options Now Available For Mylan (MYL) – Nasdaq” published on December 24, 2018, Nasdaq.com published: “Is Mylan (MYL) a Great Value Stock Right Now? – Nasdaq” on January 08, 2019. More interesting news about Mylan N.V. (NASDAQ:MYL) were released by: Nasdaq.com and their article: “Mylan (MYL) Jumps: Stock Rises 7.1% – Nasdaq” published on January 31, 2019 as well as Nasdaq.com‘s news article titled: “A War on High Drug Prices Could Boost Biosimilars – Nasdaq” with publication date: February 03, 2019.

Investors sentiment decreased to 1.5 in 2018 Q3. Its down 0.50, from 2 in 2018Q2. It is negative, as 2 investors sold MYL shares while 0 reduced holdings. 2 funds opened positions while 1 raised stakes. 212,833 shares or 40.31% less from 356,551 shares in 2018Q2 were reported. Gemmer Asset Mgmt Limited invested in 0% or 88 shares. Kentucky Retirement System, a Kentucky-based fund reported 31,609 shares. Vantage Inv Advisors Lc holds 0% or 337 shares. Gulf Fincl Bank (Uk) reported 166,890 shares.

Mylan N.V. (NASDAQ:MYL) Ratings Chart